4 investments from Kaiser

Oakland, Calif.-based Kaiser Permanente Ventures has a large venture capital arm making a diverse array of investments from digital health companies to plant-based tube feeding companies.

Advertisement

Here are four investments from Kaiser Permanente Ventures:

  1. Kaiser Permanente Ventures joined in a $75 million series C funding round for the digital patient booking platform DexCare.
  2. The health system’s venture capital arm participated with Cigna in a $34 million round for NOCD, a company that offers virtual care for obsessive-compulsive disorder.
  3. In November 2022, Kaiser led a $12 million funding round for remote care company Validic.
  4. In September 2022, Kaiser joined in on a $75 million funding round for Kate Farms, which produces plant-based nutritional products for tube or oral feeding.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.